PDF(Pubmed)
Abstract：
The imaging report is essential for the communication between physicians in patient care. The information it contains must be clear, concise with evidence-based conclusions and sufficient to support clinical decision-making. In recent years, several classification schemes and/or reporting guidelines for PET have been introduced. In this manuscript, we will review the classifications most frequently used in oncology for interpreting and reporting 18F-FDG PET imaging in lymphoma, multiple myeloma, melanoma and head and neck cancers, PSMA-ligand PET imaging for prostate cancer, and 68Ga-DOTA-peptide PET in neuroendocrine tumors (NET).
摘要：
影像学报告对于患者护理中医生之间的沟通至关重要。它包含的信息必须清晰，以证据为基础的结论简洁，足以支持临床决策。近年来,介绍了几种PET分类方案和/或报告指南。在这份手稿中,我们将回顾肿瘤学中最常用的分类，以解释和报告淋巴瘤的18F-FDGPET成像，多发性骨髓瘤,黑色素瘤和头颈癌，PSMA-配体PET显像用于前列腺癌,和68Ga-DOTA-肽PET在神经内分泌肿瘤(NET)中的应用。
